Aflibercept +/- LV5FU2 in First Line of Non-resectalbe Metastatic Colorectal Cancers
Ontology highlight
ABSTRACT: This is what the FFCD 11-01 - PRODIGE 25 trial proposes to study, as a preliminary for strategic studies evaluating the usefulness of including targeted therapeutics from the first line with aflibercept +/- LV5FU2.
DISEASE(S): First Line Of Treatment For Metastatic Colorectal Cancer,1ière Ligne De Traitement De Cancer Colorectal Métastatique,Colorectal Cancer Metastatic,Colorectal Neoplasms
PROVIDER: 2185466 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA